GC Genome Corporation (KOSDAQ:340450)
8,080.00
-100.00 (-1.22%)
Sep 19, 2025, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 191.10 billion as of September 19, 2025.
Market Cap
191.10B
Enterprise Value
147.70B
Revenue
28.70B
Ranking
n/a
PE Ratio
14,510.49
Stock Price
8,080.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 191.10B, a decrease of -27.21%. That is a compound annual growth rate of -68.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 191.10B | -1.22% |
Sep 18, 2025 | 193.46B | 0.86% |
Sep 17, 2025 | 191.81B | -2.64% |
Sep 16, 2025 | 197.01B | -2.91% |
Sep 15, 2025 | 202.92B | 6.32% |
Sep 12, 2025 | 190.86B | 0.88% |
Sep 11, 2025 | 189.21B | -0.25% |
Sep 10, 2025 | 189.68B | -0.50% |
Sep 9, 2025 | 190.63B | 0.88% |
Sep 8, 2025 | 188.97B | -1.84% |
Sep 5, 2025 | 192.52B | 2.26% |
Sep 4, 2025 | 188.26B | 2.71% |
Sep 3, 2025 | 183.29B | 4.73% |
Sep 2, 2025 | 175.02B | 0.54% |
Sep 1, 2025 | 174.07B | -3.16% |
Aug 29, 2025 | 179.75B | -1.30% |
Aug 28, 2025 | 182.11B | -0.26% |
Aug 27, 2025 | 182.58B | 0.13% |
Aug 26, 2025 | 182.35B | -1.28% |
Aug 25, 2025 | 184.71B | 1.43% |
Aug 22, 2025 | 182.11B | 5.19% |
Aug 21, 2025 | 173.12B | 0.14% |
Aug 20, 2025 | 172.89B | -3.94% |
Aug 19, 2025 | 179.98B | -1.55% |
Aug 18, 2025 | 182.82B | -1.90% |
Aug 14, 2025 | 186.37B | -0.38% |
Aug 13, 2025 | 187.08B | 0.76% |
Aug 12, 2025 | 185.66B | -0.25% |
Aug 11, 2025 | 186.13B | -2.48% |
Aug 8, 2025 | 190.86B | - |
Aug 7, 2025 | 190.86B | -1.34% |
Aug 6, 2025 | 193.46B | -2.04% |
Aug 5, 2025 | 197.48B | 6.51% |
Aug 4, 2025 | 185.42B | - |
Aug 1, 2025 | 185.42B | -5.54% |
Jul 31, 2025 | 196.30B | -2.35% |
Jul 30, 2025 | 201.03B | -0.58% |
Jul 29, 2025 | 202.21B | -0.47% |
Jul 28, 2025 | 203.16B | -0.23% |
Jul 25, 2025 | 203.63B | -1.82% |
Jul 24, 2025 | 207.42B | -0.79% |
Jul 23, 2025 | 209.07B | -1.67% |
Jul 22, 2025 | 212.62B | 0.90% |
Jul 21, 2025 | 210.73B | -1.00% |
Jul 18, 2025 | 212.86B | -1.32% |
Jul 17, 2025 | 215.70B | -0.22% |
Jul 16, 2025 | 216.17B | -0.87% |
Jul 15, 2025 | 218.06B | 3.36% |
Jul 14, 2025 | 210.97B | -3.25% |
Jul 11, 2025 | 218.06B | 4.77% |
Jul 10, 2025 | 208.13B | 0.80% |
Jul 9, 2025 | 206.47B | -0.11% |
Jul 8, 2025 | 206.71B | -1.35% |
Jul 7, 2025 | 209.55B | -1.56% |
Jul 4, 2025 | 212.86B | 2.62% |
Jul 3, 2025 | 207.42B | 0.57% |
Jul 2, 2025 | 206.23B | -3.43% |
Jul 1, 2025 | 213.57B | -0.22% |
Jun 30, 2025 | 214.04B | -2.69% |
Jun 27, 2025 | 219.95B | -3.93% |
Jun 26, 2025 | 228.94B | 3.86% |
Jun 25, 2025 | 220.43B | -3.12% |
Jun 24, 2025 | 227.52B | -1.84% |
Jun 23, 2025 | 231.78B | -3.26% |
Jun 20, 2025 | 239.58B | 8.23% |
Jun 19, 2025 | 221.37B | -1.47% |
Jun 18, 2025 | 224.68B | 2.15% |
Jun 17, 2025 | 219.95B | 0.22% |
Jun 16, 2025 | 219.48B | -5.50% |
Jun 13, 2025 | 232.25B | -9.16% |
Jun 12, 2025 | 255.67B | -2.61% |
Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.24T |
Celltrion | 37.12T |
ALTEOGEN | 25.28T |
Yuhan | 8,752.85B |
SK Biopharmaceuticals | 8,450.00B |
Peptron | 6,744.58B |
PharmaResearch | 6,316.91B |
ABL Bio | 5,473.88B |